HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Mikhail Vaynblat Zvi Zisbrod Joseph N. Cunningham, Jr Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaynblat, M. Articles by Cunningham, J. N. Search for Related Content PubMed PubMed Citation Articles by Vaynblat, M. Articles by Cunningham, J. N., Jr Related Collections Related Article

Ann Thorac Surg 1997;64:81-85
© 1997 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Cardiac Binding in Experimental Heart Failure

Divisions of Cardiothoracic Surgery and Cardiology, State University of New York-Health Science Center at Brooklyn, Brooklyn, New York

Accepted for publication January 10, 1997.

Background. Cardiomyoplasty is a potential therapy for heart failure. Its benefits are attributed to systolic augmentation (dynamic cardiomyoplasty) and prevention of cardiac dilatation (static cardiomyoplasty). To evaluate the static component, we used an artificial membrane for cardiac binding in a canine model of heart failure.

Methods. Intracoronary doxorubicin was administered weekly for 4 weeks to induce heart failure in 10 dogs, each of which was assigned to one of two treatment groups: (1) no treatment, or (2) cardiac binding. Hemodynamic data were obtained at operation and at 7 weeks after operation. Echocardiography was performed weekly.

Results. Left ventricular end-diastolic pressure and diameter, and right ventricular end-diastolic diameter increased in group 1 (from 9.6 ± 6.1 to 19.6 ± 2.3 mm Hg, p = 0.009; from 3.9 ± 0.4 to 5 ± 0.3 cm, p = 0.0013; and from 1.6 ± 0.2 to 1.9 ± 0.3 cm, p = 0.0036, respectively). Ejection fraction fell in group 1 from 0.60 ± 0.10 to 0.40 ± 0.04 (p = 0.0009) and in group 2 from 0.56 ± 0.02 to 0.40 ± 0.04 (p = 0.0001), but the difference between groups was not significant.

Conclusion. Cardiac binding reduces the ventricular dilatation associated with heart failure without exacerbating left ventricular dysfunction.

Related Article

Invited Commentary

Ignacio Y. Christlieb
Ann. Thorac. Surg. 1997 64: 85. [Extract] [Full Text]

This article has been cited by other articles:

				S. Christiansen and R. Autschbach Doxorubicin in experimental and clinical heart failure. Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 611 - 616. [Abstract] [Full Text] [PDF]

				V. Chekanov, A. Dumcius, and P. Karakozov Adaptive Cardiac Binding: A New Method for Treatment of Dilated Cardiomyopathy Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 351 - 356. [Abstract] [Full Text] [PDF]

				P. Feindt, U. Boeken, J.D. Schipke, J. Litmathe, N. Zimmermann, and E. Gams Ventricular constraint in dilated cardiomyopathy: A new, compliant textile mesh exerts prophylactic and therapeutic properties J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1107 - 1107. [Abstract] [Full Text] [PDF]

				P. Feindt, U. Boeken, J. Litmathe, and E. Gams Ventricular containment in the prophylaxis of experimental dilated cardiomyopathy Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 575 - 580. [Abstract] [Full Text] [PDF]

				H. N. Sabbah, V. G. Sharov, R. C. Gupta, S. Mishra, S. Rastogi, A. I. Undrovinas, P. A. Chaudhry, A. Todor, T. Mishima, E. J. Tanhehco, et al. Reversal of Chronic Molecular and Cellular Abnormalities Due to Heart Failure by Passive Mechanical Ventricular Containment Circ. Res., November 28, 2003; 93(11): 1095 - 1101. [Abstract] [Full Text] [PDF]

				W. F. Konertz, J. E. Shapland, H. Hotz, S. Dushe, J. P. Braun, K. Stantke, and F. X. Kleber Passive Containment and Reverse Remodeling by a Novel Textile Cardiac Support Device Circulation, September 18, 2001; 104(90001): I-270 - 275. [Abstract] [Full Text] [PDF]

				Y. Ootaki, M. Okada, T. Tsukube, and Y. Okita The Effect of Cardiomyoplasty on Left Atrial Function in Experimental Canine Models Chest, May 1, 2001; 119(5): 1526 - 1532. [Abstract] [Full Text] [PDF]

				P. A. Chaudhry, T. Mishima, V. G. Sharov, J. Hawkins, C. Alferness, G. Paone, and H. N. Sabbah Passive epicardial containment prevents ventricular remodeling in heart failure Ann. Thorac. Surg., October 1, 2000; 70(4): 1275 - 1280. [Abstract] [Full Text] [PDF]

				H. R. Shah, M. Vaynblat, L. Salciccioli, P. Impellizzeri, J. N. Cunningham Jr, and M. Chiavarelli Composite cardiac binding in experimental heart failure Ann. Thorac. Surg., February 1, 2000; 69(2): 429 - 434. [Abstract] [Full Text] [PDF]

				S. Goldstein Passive ventricular restaint Cardiovasc Res, December 1, 1999; 44(3): 468 - 469. [Full Text] [PDF]

				J.M Power, J Raman, A Dornom, S.J Farish, L.M Burrell, A.M Tonkin, B Buxton, and C.A Alferness Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy Cardiovasc Res, December 1, 1999; 44(3): 549 - 555. [Abstract] [Full Text] [PDF]

				J. H. Oh, V. Badhwar, B. D. Mott, C. M. Li, and R. C.-J. Chiu The effects of prosthetic cardiac binding and adynamic cardiomyoplasty in a model of dilated cardiomyopathy J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 148 - 153. [Abstract] [Full Text]